Meeting Banner
Abstract #4354

Towards Novel Contrast Agents for Bowel Imaging Based on 19F Compounds

Rolf Lamerichs1, 2, Marije van der Paardt2, Aart Nederveen2, Jaap Stoker2, Raquel Diaz-Lopez, 13

1Philips Research, Eindhoven, Netherlands; 2Academic Medical Center, Amsterdam, Netherlands; 3VU University Medical Center, Amsterdam, Netherlands

Contrast agents based on fluorine (19F) compounds have several advantages over T1 or T2 based contrast agents. Here we show the use of non-targeted polymeric microcapsules for bowel imaging. These microcapsules contain perfluoro-octylbromide (PFOB). For the detection of the fluorine signal we used the Fluorine ultrafast Turbo Spectroscopic Imaging (F-uTSI) sequence. This sequence can be applied to any PFC compound. The data show that the polymeric microcapsules can be developed into promising 19F-MRI contrast agents for bowel imaging using 19F spectroscopic imaging methods. The bowel transit time of these agents is around 10 hrs in black mice.

Abstract PDF E-Poster Video

Keywords

accordance administration agent agents allowing already amount anatomical anesthesia animal animals applied around assess atropine black body bowel bromide capabilities capsules cecum cell characterized chemical collected color compound contrast created decode detection developed done dual emulsions encapsulated encapsulating euthanasia expected fast fluorine gradient guidelines hence human in vivo integrating intensity intra isotropic maintained mater medical medicine mice micro modified molecular naturally need novel occur oral organs overlaid particles polymeric post prepared process promising proton reached reconstruction recorded removed resolution sacrificed scanning several shell sign since software spatial specificity stable stoker suitable taken targeted thereby towards tract transit turbo ultra ultrafast whole